TipRanks
Shinpoong Pharmaceutical Co., Ltd. (KR:019170)
:019170
South Korea Market
019170
Shinpoong Pharmaceutical Co., Ltd.
RESEARCH TOOLSreports

Shinpoong Pharmaceutical Co., Ltd. (019170) Income Statement

― Followers

Shinpoong Pharmaceutical Co., Ltd. Income Statement

Last quarter (Q2 2026), Shinpoong Pharmaceutical Co., Ltd.'s total revenue was ₩63.89B, an increase of 8.99% from the same quarter last year. In Q2, Shinpoong Pharmaceutical Co., Ltd.'s net income was ₩-8.01B. See Shinpoong Pharmaceutical Co., Ltd.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
₩ 234.68B₩ 221.09B₩ 200.23B₩ 209.29B₩ 189.24B
Gross Profit
₩ 102.37B₩ 81.80B₩ 80.28B₩ 77.97B₩ 77.39B
Operating Expenses
₩ 88.11B₩ 102.26B₩ 127.60B₩ 111.99B₩ 91.69B
Depreciation and Amortization
₩ 11.39B₩ 11.96B₩ 11.91B₩ 12.80B₩ 12.68B
EBITDA
₩ 25.65B₩ -27.14M₩ -39.81B₩ -21.92B₩ 3.89B
Operating Income
₩ 14.26B₩ -20.46B₩ -47.39B₩ -34.02B₩ -9.04B
Other Income/Expenses
₩ -5.80B₩ 5.83B₩ -6.05B₩ -762.85M₩ -720.04M
Pretax Income
₩ 8.45B₩ -14.62B₩ -53.44B₩ -34.78B₩ -8.99B
Net Income
₩ 8.83B₩ -15.39B₩ -57.33B₩ -35.31B₩ -11.53B
Per Share Metrics
Basic EPS
₩ 172.00₩ -300.17₩ -1.12K₩ -688.79₩ -224.84
Diluted EPS
₩ 172.00₩ -300.17₩ -1.12K₩ -688.79₩ -224.84
Weighted Average Shares Outstanding
 55.19M 51.26M 51.23M 51.26M 51.26M
Weighted Average Shares Outstanding (Diluted)
 55.19M 51.26M 51.26M 51.26M 51.26M
Currency in KRW

Shinpoong Pharmaceutical Co., Ltd. Earnings and Revenue History